Hepaxa: BASF’s new product control chronic liver disease

Hepaxa: BASF’s new product to control chronic liver disease

5:14 AM, 23rd February 2018
Hepaxa bottles for adults and pediatrics,
BASF, Hepaxa, alcoholic fatty liver disease, chronic liver disease.

FLORHAM PARK/ANN ARBOR, US: BASF Corporation said that it is introducing Hepaxa, a product that can help tens of millions of patients manage non-alcoholic fatty liver disease (NAFLD), one of the most common forms of chronic liver disease.

Providing highly concentrated and pure eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), Hepaxa is the first product in US, specifically designed to address a buildup of fat in the liver, known as steatosis, in NAFLD patients. Hepaxa will be distributed nationally through DIEM Labs LLC.

Studies have shown that NAFLD patients are deficient in EPA and DHA. Hepaxa increases the levels of these important fatty acids in the blood, which improves the liver´s ability to process excessive fat stored there while inhibiting the conversion of dietary carbohydrates into fat.

A 2017 BASF study has shown that Hepaxa is effective and safe in the dietary management of NAFLD patients. BASF plans to publish the clinical results of this product-specific human intervention trial in the second half of 2018.

Hepaxa is manufactured using a patented purification technology removing persistent organic pollutants and other unwanted lipids such as cholesterol, which are naturally found in all fish oil-based products. Research has shown that one specific pollutant, PCB 153, is particularly harmful to NAFLD patients. The liver function of NAFLD patients is compromised and it is important to avoid additional exposure to unwanted components of traditional fish oil.

“BASF’s launch of Hepaxa is the result of our research and development efforts targeting liver health, where we are capitalizing on our unique scientific competencies. With NAFLD rapidly becoming a major public health concern worldwide, we are proud to now offer this first-to-market, dedicated solution for NAFLD patients in US,” said Christoph Garbotz, head of commercial management advanced health solutions, BASF.

“Hepaxa is uniquely positioned to support the dietary management of steatosis in NAFLD patients. Healthcare providers are continuously looking for an adjunctive treatment to exercise and weight loss therapy to recommend to their patients. Hepaxa can now be used to begin turning around NAFLD in as little as six months,” added Tim Prince, director of sales at DIEM Labs.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Merck to invest €40 mn to boost manufacturing, distribution in Asia

DARMSTADT, GERMANY: Merck announced an additional investment of €40 million to build a robust manufacturing and distribution platform in Asia ove ...

Read more
ThyssenKrupp bags caustic soda contract from GACL-Nalco JV

MUMBAI, INDIA: ThyssenKrupp Industrial Solutions has been awarded a contract by GACL-Nalco Alkalies & Chemicals Private Limited (GNAL), for its gr ...

Read more
Kraton intents to initiate term loan reprice, maturity extension

HOUSTON, US: Kraton Corporation (KRA) and certain of its wholly-owned subsidiaries said that they intend to amend the existing senior secured ter ...

Read more
DGH may review plan to sell 60 pc stake in ONGC, Oil India fields

MUMBAI/NEW DELHI, INDIA: Directorate General of Hydrocarbons (DGH) may be rethinking its plan to sell 60 percent stake in hydrocarbon blocks held ...

Read more
Clariant re-launches innovative skin care ingredient to resist pollution effects

MUTTENZ, SWITZERLAND: Clariant International Ltd has re-launched its innovative skin defender against pollution and ageing, RedSnow, after skin explan ...

Read more
Organic acid a feed hygiene alternative for formaldehyde: Perstorp

PERSTORP, SWEDEN: Towards the end of 2017, the European Union denied the authorization of formaldehyde as a preservative and hygiene condition enhance ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X